Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New, highly selective I1 receptor ligand with blood pressure-lowering effects

May 31, 1999

AGI-1067, a new vascular protectant, advances through the development pipeline

May 31, 1999

Long-term AT1 receptor blockade with fonsartan proves highly beneficial in SHR-SP

May 28, 1999

PD-098059 inhibits AII-induced MAPK activation in myocardial cells

May 28, 1999

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

May 26, 1999

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

May 26, 1999

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

May 25, 1999

BASF describes new, selective ECE inhibitors

May 25, 1999

Glaxo Wellcome launches first drug to treat PPH in Japan

May 25, 1999

MediGene discovers target gene for DCM therapy

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.